 Connection
Adam Gilden to Humans
This is a "connection" page, showing publications Adam Gilden has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.076 |
|
|
|
-
Gilden AH, Catenacci VA, Taormina JM. Obesity. Ann Intern Med. 2024 05; 177(5):ITC65-ITC80.
Score: 0.021
-
Gilden AH, Catenacci VA. Time-Restricted Eating for Treatment of Obesity? The Devil Is in the (Counseling) Details. Ann Intern Med. 2023 07; 176(7):999-1000.
Score: 0.020
-
Wadden TA, Gilden AH. Steady progress in the behavioral management of obesity in primary-care settings - but innovation needed. Obesity (Silver Spring). 2022 08; 30(8):1535-1536.
Score: 0.019
-
Chao AM, Gilden A, Wadden TA. Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety. PLoS Med. 2026 Jan; 23(1):e1004871.
Score: 0.006
-
Wadden TA, Chao AM, Moore M, Tronieri JS, Gilden A, Amaro A, Leonard S, Jakicic JM. The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities. Curr Obes Rep. 2023 Dec; 12(4):453-473.
Score: 0.005
-
Tucker S, Bramante C, Conroy M, Fitch A, Gilden A, Wittleder S, Jay M. The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings. Curr Obes Rep. 2021 Sep; 10(3):396-408.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|